- Home
- FLYW vs QURE Comparison
FLYW vs QURE Comparison
Compare FLYW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLYW | QURE |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | FLYW | QURE |
|---|---|---|
| Price | $14.69 | $25.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 12 |
| Target Price | $14.27 | ★ $58.55 |
| AVG Volume (30 Days) | 1.3M | ★ 2.3M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $583,031,000.00 | $15,751,000.00 |
| Revenue This Year | $25.20 | N/A |
| Revenue Next Year | $14.98 | $153.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.71 | N/A |
| 52 Week Low | $8.20 | $7.76 |
| 52 Week High | $21.31 | $71.50 |
Technical Indicators
Market Signals| Indicator | FLYW | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 58.45 | 51.73 |
| Support Level | $14.33 | $22.11 |
| Resistance Level | $15.25 | $24.43 |
| Average True Range (ATR) | 0.43 | 1.48 |
| MACD | -0.01 | 0.56 |
| Stochastic Oscillator | 66.87 | 48.42 |
Price Performance
Historical ComparisonAbout FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.